期刊文献+

α干扰素增强骨肉瘤细胞对依托泊苷敏感性的实验研究 被引量:4

Experimental study of IFN-α for enhancing sensitivity to Etoposide in human osteosarcoma cells
暂未订购
导出
摘要 目的探讨α干扰素(IFN-α)在人骨肉瘤U2OS和MG63细胞中对依托泊苷敏感性的作用及其机制。方法采用IFN-α和依托泊苷单独或联合处理骨肉瘤U2OS和MG63细胞72 h,应用流式细胞术和DNA Ladder检测细胞凋亡的变化,Western blot法检测PARP、p53、MDM2、Bax、Bcl-2的表达。结果流式细胞术表明IFN-α在p53正常的U2OS细胞中明显增强依托泊苷诱导的凋亡(P<0.05),却对依托泊苷诱导p53突变的MG63细胞凋亡无明显影响(P>0.05);DNA Ladder表明与单药组相比,IFN-α与依托泊苷联用72 h在U2OS细胞出现明显的DNA梯形条带,而在MG63细胞中无此现象;Western blot结果表明在U2OS细胞中联合用药组出现PARP的明显裂解活化,并且IFN-α明显增强依托泊苷引起的p53信号通路p53、MDM2、Bax等凋亡基因的表达,并抑制抗凋亡基因Bcl-2的表达,而在MG63细胞中则无此现象。结论 IFN-α能够通过激活p53依赖性信号通路增强依托泊苷诱导的骨肉瘤U2OS细胞凋亡,联合应用IFN-α和传统化疗药物如依托泊苷可能成为提高骨肉瘤化疗敏感性的有效途径。 Objective To study effect of IFN-α on the sensitivity to Etoposide in human osteosarcoma U2OS and MG63 cells with its molecular mechanisms. Methods U2OS and MG63 cells were treated with IFN-α and Etoposide, alone or in combination, for 72 h. Flow cytometry analysis and DNA Ladder were used to examine apoptosis. Western blot was used to determine expression of PARP, p53, Bax, Mdm2 and Bcl-2. Results IFN-α enhanced Etoposide-induced apoptosis in p53-wild U2OS cells(P 0.05), but not p53-mutant MG63 cells(P 0.05). IFN-α+Etoposide combination result in obvious DNA Ladder in U2OS, but not MG63 cells and activation of PARP in U2OS cells. The enhanced apoptosis was associated with the accumulation of transcriptionally active p53 accompanied with the increased Bax and MDM2, as well as decreased Bcl-2, in U2OS cells, which was not observed in MG63 cells. Conclusion IFN-α enhances Etoposide-induced apoptosis in human osteosarcoma U2OS cells by activation of p53-dependent signal pathway. This work implies that rational combination with IFN-α and chemotherapy including Etoposide may be a useful strategy for enhancing the chemosensitivity of osteosarcoma.
出处 《中国医药导报》 CAS 2014年第7期4-7,14,共5页 China Medical Herald
基金 广东省医学科研基金立项课题(编号A2013756) 广东省医学科学技术研究课题(编号B2009249)
关键词 Α干扰素 依托泊苷 骨肉瘤 凋亡 P53 IFN-α Etoposide Osteosarcoma Apoptosis p53
  • 相关文献

参考文献16

  • 1De Saint SN,Fletcher CD. Soft-tissue sarcomas: a update [J]. Eur J Surg Oncol, 1999,25(2):215-220.
  • 2Prejean C ,Colamonici OR. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling [J]. Semin Cancer Biol, 2000,10(2) : 83-92.
  • 3Manara MC, Serra M, Benini S, et al. Effectiveness of Type I interferons in the treatment of multidrug resistant os- teosarcoma cells [J]. Int J Oncol, 2004,24 (2) : 365-372.
  • 4Stark GR,Kerr IM,Williams BR,et al. How cells respond to interferons [J]. Annu Rev Biochem, 1998,67 (3) :227-264.
  • 5郭子文,许晓军.干扰素辅助小剂量HA方案治疗慢性粒细胞白血病29例疗效观察[J].中国医药导报,2012,9(3):37-38. 被引量:6
  • 6Bruland OS,Pihl A. On the current management of osteosar- coma. A critical evaluation and a proposal for a modified treatment strategy [J]. Eur J Cancer, 1997,33 (11 ) : 1725- 1731.
  • 7Hande KR. Etoposide:four decades of development of a topoisomerase II inhibitor [J]. Eur J Cancer, 1998,34 (10) : 1514-1521.
  • 8Gavrieli Y, Sherman Y,Ben S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation [J]. J Cell Biol, 1992,119(3):493-501.
  • 9Smulson ME, Simbulan-Rosenthal CM,Boulares AH, et al. Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1 [J]. Adv Enzyme Regul,2000,40(2) :183-215.
  • 10何均辉,邹秀玲,李忠楚,陆忠奎.P53蛋白在胃癌中的表达分析[J].中国医药导报,2012,9(5):86-86. 被引量:7

二级参考文献29

  • 1杨晶,刘丽娜,吕申.TGF-β_1、PTEN、p53在胃癌组织中的表达及意义[J].中国自然医学杂志,2009,10(3). 被引量:7
  • 2陈艺丹,杨玉珍,宋娟.Cyclin Gl、Mdm2和P53在胃癌组织中的表达及相关性研究[J].胃肠病学和肝病学杂志,2007,16(2):127-129. 被引量:4
  • 3Dent R,Trudeau M,Pritchard KI,et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res,2007,13 (15) :4429-4434.
  • 4Carey LA,Perou CM,Livasy CA,et al. Race,breast cancer subtypes,and survival in the Carolina Breast Cancer Study[J]. JAMA,2006,295 (21): 2492-2502.
  • 5Steponaviciene L, Lachej-Mikeroviene N, Smailyte G,et al. Triple nega- tive breast cancer: adjuvant chemotherapy effect on survival[J]. Adv Med Sci, 2011,56 ( 2 ) : 285-290.
  • 6Dawson SJ,Makretsov N,Blows FM,et al. Bcl-2 in breast cancer: A favourable prognostic marker across mo|ecular subtypes and independent of adjuvant therapy received[J]. Br J Cancer, 201 O, 103 (5) : 668-675.
  • 7Singletary SE,Allred C,Ashley P,et al. Staging system for breast can- cer:revisions for the 6th edition of the AJCC Cancer Staging Manual[J]. Surg Clin North Am,2003,83(4):803-819.
  • 8Luna-More S,Casquero S,Perez-Me|lado A,et al. Importance of estro- gen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow- up of 54 [J]. Pathol Res Pract, 2000,196( 1 ) : 35-59.
  • 9Wang S,Yang D,Lippman ME. Targeting Bcl-2 and BcI-XL with non- peptidic snmll- molecule antagonists[J]. Semin Oneo1,2003,30(5): 132-142.
  • 10KalleL-Bayoudh l,Hassen HB,Khabir A,et al. Bcl-2 expression and triple negative profile in breast carcinoma[J]. Med Oncol, 2011,28 ( 1 ) : $55-61.

共引文献18

同被引文献50

  • 1周梦婷,姚玉红.1例骶骨骨巨细胞瘤围手术期护理[J].医学信息(医学与计算机应用),2016,29(30):292-293. 被引量:1
  • 2楼燕凤,曹爽,王蔚雯.62例膝关节周围骨肉瘤人工肿瘤型假体置换术的护理[J].医学研究生学报,2011,24(5):526-529. 被引量:19
  • 3王广宇,王金成,刘鹏.骨肉瘤的治疗方法[J].中国老年学杂志,2014,34(9):2604-2606. 被引量:9
  • 4Morrow JJ,Khanna C Osteosarcoma genetics and epigenetics:emerging biology and candidate therapies [J]. Crit Rev Oncog,2015,20(3-4):173-197.
  • 5Moriarity BS,Otto GM ,Rahrmann EP,et al. A SleepingBeauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis [J].Nat Genet,2015,47(6) ;615-624.
  • 6Liu F,Chang H,Xu W,et al. The effects of LivinshRNAon the response to cisplatin in HepG2 cells [J]. Oncol Lett,2015,10(5):2957-2961.
  • 7Gurung P, Kanneganti TD. Novel Roles for Caspase-8 in*IL-lp and Inflammasome Regulation [J]. Am J Pathol,2015,185(l):17-25.
  • 8隋官杰,曲珍,罗含笑,等.骨膜骨肉瘤病理组织学诊断体会[C]//全国软组织和骨肿瘤病理诊断学术研讨会论文汇编,2004:121.
  • 9Huang S,0kamoto K,Yu C,et aL p62/Sequestosome~l Up-regulation Promotes ABT -263 -induced Caspase -8Aggregation/Activation on the Autophagosome [I]. J Biol Chem,2013,288(47):33654-33666.
  • 10Basu -Roy U,Basilico C,Mansukhani A. Perspectives oncancer stem cells in osteosarcoma [J]. Cancer lett, 2013,338(1):158-167.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部